Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Roberto J Bernardo"'
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 1, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/0589bd16064242df8b55ebdd73af5ad3
Autor:
S. Talal Hussain, MD, Huzaifa A. Jaliawala, MD, Daniel Zhao, PhD, Sardar Hassan Ijaz, MD, Janice Tsui, PharmD, BCPS, Bobby Chasteen, RRT, Brent R. Brown, MD, Roberto J. Bernardo, MD, MS
Publikováno v:
Critical Care Explorations, Vol 5, Iss 1, p e0845 (2023)
IMPORTANCE:. Aerosolized prostacyclins are frequently used in patients with severe acute respiratory distress syndrome and refractory hypoxia. Previous studies have shown improvement in oxygenation with use of pulmonary vasodilators such as iloprost
Externí odkaz:
https://doaj.org/article/7c9424a6ae44442faed48dde20d6d343
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 1, Pp n/a-n/a (2022)
Abstract The second hit hypothesis in pulmonary hypertension refers to the development of pulmonary vascular disease in individuals at risk, after an additional exposure or “hit” to factors with potential injury to the pulmonary circulation, such
Externí odkaz:
https://doaj.org/article/8f3e4768804f4e2f8452d1527795564c
Autor:
Christopher A. Thomas, Justin Lee, Roberto J. Bernardo, Ryan J. Anderson, Vladimir Glinskii, Yon K. Sung, Kristina Kudelko, Haley Hedlin, Andrew Sweatt, Steven M. Kawut, Rishi Raj, Roham T. Zamanian, Vinicio de Jesus Perez
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Pulmonary hypertension is a complication of chronic lung diseases (PH-CLD) associated with significant morbidity and mortality. Management guidelines for PH-CLD emphasize the treatment of the underlying lung disease, but the role of PH-ta
Externí odkaz:
https://doaj.org/article/37a7b37894ae478fa5990c4775f90cae
Autor:
Lucilla Piccari, Roberto J. Bernardo, Diego Rodríguez-Chiaradía, Patrizio Vitulo, S. John Wort, Sandeep Sahay
Publikováno v:
Pulmonary Circulation, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/c92d1a7aacc04a40901476a31ad5c3e0
Publikováno v:
Breathe, Vol 15, Iss 3, Pp 241-243 (2019)
Externí odkaz:
https://doaj.org/article/9aeba11c7e3c477faef7284b1f19c7a7
Publikováno v:
Clinics in Chest Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9ce5c1f7cc0cb3d84db6fabd3997876
https://doi.org/10.1016/j.ccm.2023.03.010
https://doi.org/10.1016/j.ccm.2023.03.010
Publikováno v:
JACC: Case Reports. 4:497-500
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b13dc42ec6ecd533ebbabe932e9dfef
https://doi.org/10.1016/j.jaccas.2022.02.013
https://doi.org/10.1016/j.jaccas.2022.02.013
Publikováno v:
Advances in Pulmonary Hypertension. 21:44-48
Pulmonary arterial hypertension (PAH) is a chronic, progressive, and debilitating disease associated with increased cardiopulmonary morbidity and mortality. Current knowledge is derived from registries and landmark clinical trials, although concern e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03f5c2bc6a10e4e4f2612a5160944640
https://doi.org/10.21693/1933-088x-21.2.44
https://doi.org/10.21693/1933-088x-21.2.44
Publikováno v:
Clinical Lung Cancer. 22:e153-e156
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6abcf15fe0b9a6cbe73ff7e8e467f27
https://doi.org/10.1016/j.cllc.2020.09.020
https://doi.org/10.1016/j.cllc.2020.09.020